{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:54:34Z","timestamp":1791078874239,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.jaad.2007.07.012","type":"journal-article","created":{"date-parts":[[2008,4,13]],"date-time":"2008-04-13T08:15:53Z","timestamp":1208074553000},"page":"S88-S91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"S1","title":["Complete clinical remission of tumor-stage mycosis fungoides after acute extensive skin necroses, granulomatous reaction, and fever under treatment with bexarotene, vorinostat, and high-dose fenofibrate"],"prefix":"10.1016","volume":"58","author":[{"given":"Matthias","family":"Steinhoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Roewert-Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansgar","family":"Lukowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chalid","family":"Assaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Sterry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2007.07.012_bib1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2133.1970.tb06839.x","article-title":"Granulomatous mycosis fungoides","volume":"82","author":"Ackerman","year":"1970","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2007.07.012_bib2","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1097\/00000478-200210000-00002","article-title":"Cutaneous lymphomas with prominent granulomatous reaction: a potential pitfall in the histopathologic diagnosis of cutaneous T- and B-cell lymphomas","volume":"26","author":"Scarabello","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaad.2007.07.012_bib3","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1468-3083.2000.00047.x","article-title":"Granulomatous mycosis fungoides: report of two cases and review of the literature","volume":"14","author":"Fischer","year":"2000","journal-title":"J Eur Acad Dermatol Venerol"},{"key":"10.1016\/j.jaad.2007.07.012_bib4","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2007.07.012_bib5","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2133.2005.07034.x","article-title":"Sezary syndrome associated with granulomatous lesions during treatment with bexarotene","volume":"154","author":"Ruiz-de-Casas","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2007.07.012_bib6","first-page":"2212","article-title":"Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases","volume":"95","author":"Vergier","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2007.07.012_bib7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0925-5710(97)00584-7","article-title":"Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment","volume":"66","author":"Imashuku","year":"1997","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jaad.2007.07.012_bib8","first-page":"29","article-title":"Ost A, and the FHL Study Group of the Histiocyte Society. Diagnostic guidelines for hemophagocytic lymphohistiocytosis","volume":"18","author":"Henter","year":"1991","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jaad.2007.07.012_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3816\/CLM.2000.n.012","article-title":"Enterococcal eschars in cutaneous T-cell lymphoma tumors: a distinct clinical entity","volume":"2","author":"Duvic","year":"2000","journal-title":"Clin Lymphoma"},{"key":"10.1016\/j.jaad.2007.07.012_bib10","first-page":"1234","article-title":"Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action","volume":"8","author":"Zhang","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaad.2007.07.012_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1182\/blood-2006-06-025999","article-title":"Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)","volume":"109","author":"Duvic","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2007.07.012_bib12","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.0022-202X.2005.23925.x","article-title":"Selective induction of apoptosis by histone deacetylase inhibitor SAHA in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action","volume":"125","author":"Zhang","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2007.07.012_bib13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/35106036","article-title":"The promise of retinoids to fight against cancer","volume":"1","author":"Altucci","year":"2001","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jaad.2007.07.012_bib14","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1160\/TH03-04-0250","article-title":"Statin and fibrate treatment of combined hyperlipidemia: the effects on some novel risk factors","volume":"92","author":"Sebestjen","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaad.2007.07.012_bib15","first-page":"546","article-title":"A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands","volume":"6","author":"Crowe","year":"2004","journal-title":"Cancer Res"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962207011322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962207011322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:08:31Z","timestamp":1759270111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962207011322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0190962207011322"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2007.07.012","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complete clinical remission of tumor-stage mycosis fungoides after acute extensive skin necroses, granulomatous reaction, and fever under treatment with bexarotene, vorinostat, and high-dose fenofibrate","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2007.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}